ArticleGenetics in medicine open2025
Trio exome analysis is a valuable tool for genetic diagnosis of epilepsy in Mali.
Article in Genetics in medicine open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
33 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Trio exome sequencing is widely used for various disorders. We investigated the utility of this method to identify genetic causes of epilepsy in Mali. Methods: We enrolled patients with epilepsy suspected of an underlying genetic etiology. Exome sequencing data from those with a minimum of a trio (proband and both biological parents) were analyzed to identify and classify potential causative genetic variants. Results: We sequenced 159 individuals, including 57 patients with epilepsy from 42 families, the largest trio sequencing cohort for epilepsy in sub-Saharan Africa. Of these, 16 families (38%) received a putative molecular diagnosis, with autosomal recessive inheritance seen in 7 of 16 (44%) and de novo events in 9 of 16 (56%). The 17 total variants were classified as pathogenic ( Conclusion: Our findings illuminate a significant genetic contribution to epilepsy in Mali with a substantial genetic heterogeneity, as well as the utility of trio exome sequencing for efficient diagnosis. This further emphasizes the persistent and critical need for greater inclusivity in genomic research and implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.